News & Updates

Show Multimedia Only

Glucose-lowering therapy tied to reduced risk of depression in T2D

23 Jun 2026

Exposure to several glucose-lowering drugs appears to have a protective effect on the risk of depression in individuals with type 2 diabetes (T2D), according to a population-based cohort study in Hong Kong.

Glucose-lowering therapy tied to reduced risk of depression in T2D

23 Jun 2026

ARACOG: Is there a difference in cognitive effects between darolutamide and enzalutamide?

23 Jun 2026 by

ARACOG, a phase II randomized trial, reports a significantly greater decline in objectively assessed cognitive function for advanced prostate cancer patients treated with enzalutamide vs darolutamide over 24 weeks, according to data presented at ASCO 2026.

ARACOG: Is there a difference in cognitive effects between darolutamide and enzalutamide?

23 Jun 2026

Chiauranib extends PFS in platinum-resistant ovarian cancer, including in anti-angio–exposed patients

23 Jun 2026 by

Chiauranib plus weekly paclitaxel significantly extends progression-free survival (PFS) in patients with platinum-resistant or -refractory ovarian cancer, including those previously treated with anti-angiogenic agents, according to the findings of the phase III CHIPRO trial presented at ASCO 2026.

Chiauranib extends PFS in platinum-resistant ovarian cancer, including in anti-angio–exposed patients

23 Jun 2026

Relative fat mass predicts stroke

22 Jun 2026

Relative fat mass is strongly associated with incident stroke, especially ischaemic stroke, as shown in a study.

Relative fat mass predicts stroke

22 Jun 2026

Ocrelizumab slows hand function decline in multiple sclerosis patients

22 Jun 2026 by

Treatment with ocrelizumab helps delay progression of disability, especially of the upper limb, in a broad population of patients with primary progressive multiple sclerosis (PPMS), including those who are older and have more advanced disease, according to the phase 3b ORATORIO-HAND trial.

Ocrelizumab slows hand function decline in multiple sclerosis patients

22 Jun 2026

Liver transplant recipients at increased risk of coronary atherosclerosis

22 Jun 2026

The prevalence and severity of coronary atherosclerosis are significantly higher among recipients of liver transplant than the general population, a study has shown.

Liver transplant recipients at increased risk of coronary atherosclerosis

22 Jun 2026

Direct-acting antivirals improve survival in patients with HCV-related HCC

22 Jun 2026 by

A recent study in UK has shown a significant proportion of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) initiating direct-acting antiviral (DAA) therapy, resulting in improvements in sustained virological response (SVR) rates.

Direct-acting antivirals improve survival in patients with HCV-related HCC

22 Jun 2026

Testosterone level decline varies in older men

22 Jun 2026

A recent study has noted a broad range of total testosterone levels in older community-dwelling men, with a substantial proportion in a range deemed hypogonadal.